NCT00005912View on ClinicalTrials.gov

Voriconazole to Prevent Systemic Fungal Infections in Children

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

January 31, 2001

Conditions
AspergillosisCandidiasisFungal DiseasesMycoses
Interventions
DRUG

Voriconazole

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005912 - Voriconazole to Prevent Systemic Fungal Infections in Children | Biotech Hunter | Biotech Hunter